GM
Geoff Meacham Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
70
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
52.4%
Neutral
47.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $58 |
22%
upside
| 2 | +6.7% |
0
%
| 4 Mar ‘26 21 hours ago |
|
|
|
Buy
Maintained
| $120 |
39%
upside
| 2 | +8.2% |
0
%
| 2 Mar ‘26 2 days ago |
|
|
|
Buy
Initiated
| $85 |
80%
upside
| 1 | +3.3% |
0
%
| 2 Mar ‘26 3 days ago |
|
|
|
Neutral
Downgraded
| $115 |
1%
upside
| 1 | +77% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $19 |
26%
upside
| 1 | +26% |
0
%
| 20 Feb ‘26 13 days ago |
|
|
|
Neutral
Maintained
| $215 |
13%
upside
| 3 | – |
–
| 9 Feb ‘26 23 days ago |
|
|
|
Neutral
Maintained
| $64 |
3%
upside
| 1 | – |
–
| 6 Feb ‘26 26 days ago |
|
|
|
Neutral
Maintained
| $120 |
0%
downside
| 3 | – |
–
| 4 Feb ‘26 28 days ago |
|
|
|
Neutral
Maintained
| $345 |
9%
downside
| 1 | – |
–
| 4 Feb ‘26 28 days ago |
|
|
|
Neutral
Maintained
| $230 |
3%
downside
| 1 | +7.9% |
0
%
| 27 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $156 |
5%
upside
| 2 | +8.3% |
0
%
| 27 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $50 |
5%
upside
| 1 | +15% |
0
%
| 27 Jan ‘26 1 month ago |
|
|
|
Buy
Initiated
| $50 |
232%
upside
| 1 | +18% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $115 |
21%
upside
| 1 | +16% |
0
%
| 8 Dec ‘25 2 months ago |
|